Training The Leaders Of Tomorrow With Meril Life Sciences’ Future Leader Training Program

At Meril Life Sciences Pvt. Ltd. it is our objective to identify unmet clinical requirements and produce relevant medical devices to address these requirements with immediate turnaround cycles. Such an objective can only be achieved through dedication and hard work that Merilians put in at every stage to make this goal a reality. With our enthusiastic and diverse R&D team, we aim to make healthcare solutions more accessible for doctors and patients alike. To meet these high standards we began the Future Leaders Program, an initiative by the Meril HR team to ignite the leader in each Merilian and take the company to new heights.

The Future Leader Training Program

We at Meril Life Sciences Pvt. Ltd. have always believed that leadership does not lie in the position, but the actions a person takes. We know that every employee has the potential of being the next leader and trendsetter for the company. Thus, the Future Leader Training Program began on 17th June 2019 with the first meeting being held at Takshashila Hall at Meril Academy. 250 Merilians were hand-picked by the management team from the manufacturing and administrative divisions for this initiative. The aim and function of the Future Leader Training Program is to facilitate rotations in and across functions of the Meril Life Sciences teams and allow employees and future leaders to learn about these medical devices in accelerated learning environments.

Rewarding and fun experience

Meril management teams believe that the Future Leader Training Program will be an incredibly rewarding and fun learning experience for employees. Such programs help improve relations among employees, hone people skills and their positive effects lead to employees becoming better and more authentic leaders. Developing these employees and their skills will be exactly what is required to take Meril Life Sciences Pvt. Ltd. from good to great.

Challenging and purposeful opportunities

The first session was conducted by Dr. Hemchandra Panjikar, Group Head HR at Meril Life Sciences India Pvt Ltd, who spoke about and gave examples from the book “The 7 Habits of Highly Effective People.” The 250 Merilians hand-picked for this role, have all been identified as potential emerging leaders within these divisions. Based on this, these future leaders will be taking on challenging and purposeful opportunities that accelerate their readiness to take on leadership roles.

Along with our complete dedication towards the design and development of novel, state-of-the-art and best in class devices, Meril Life Sciences Pvt. Ltd. is also deeply committed to conducting trials that allow for the alleviation of human suffering.With our Future Leader Training Program and other endeavours we at Meril Life Sciences hope to truly create a better and brighter future for all of us.

For more details, visit our blog here: https://www.merillife.com/blog/our-people/training-the-leaders-of-tomorrow-with-meril-life-sciences-future-leader-training-program

TAVR Certification Program To Increase Proficiency Of Medical Professionals In The Latest Technology to Treat Coronary Artery Diseases

Meril Academy is one of the largest and most advanced training centers in Asia, which has been visited by more than 10,000 healthcare professionals from all across the globe. Built with the cosmic vision of bridging the gap between the rapid advancement in technology and its impact on patients and surgeries, Meril Academy enables healthcare professionals to learn more about these updated technologies. This healthcare education is provided through live cases, live lectures, complex case presentations and other informative lectures delivered by seasoned medical practitioners to help improve surgical outcomes.

Coronary artery diseases are currently the leading cause of death worldwide. This means that the number of patients suffering from aortic stenosis and other cardiovascular diseases is constantly on the rise. Transcatheter Aortic Valve Implantation (TAVI) and Transcatheter Aortic Valve Replacement (TAVR) are fairly new procedures that are recommended to patients suffering from aortic stenosis with high and intermediate-risk levels. These procedures use a minimally invasive surgical approach to repair a damaged heart valve by placing a replacement valve into the faulty artery. To speed up the learning process of the newly introduced technology we organized the Myval Certification program, to reach out to interventional cardiologists and cardiac surgeons and train them in the use of this technology.

A one-day course was held on 12th January 2019 with 35 delegates participating from all over India and renowned interventional cardiologist Dr. G. Sengottuvelu acting as course director for the 1st TAVR certification program. The objective of the program was to train interventional cardiologists and cardiac surgeons on the basis of TAVR therapy by creating a blend of didactic situations and hands-on simulations. Dr. Ravinder Singh Rao, Dr. Anmol Sonawane and Dr. Sanjiv Gupta were the faculty for this program. The first TAVR certification program was a successful endeavor signifying the start of the learning process.

It was followed by the 2nd TAVR certification program held on 16th March 2019. This program agglomerated 61 interventional cardiologists and cardiac surgeons across India, with Dr. Ravinder Singh Rao and Dr. Vijay Kumar presiding as course directors. The programs covered topics such as imaging of TAVR, step-by-step TAVR with Myval and TAVR in high-risk patients. The session further went on to discuss some interesting cases that used the Myval procedure to help treat patients.

Through initiatives such as the Myval TAVR certification program and Meril Academy, we at Meril Life have built products, training programs, and facilities which allow us to compete on an international stage. Only through education and preparation for the future can we forge a path that will lead to healthcare that is accessible to everyone.

Visit our blog post for more details: https://www.merillife.com/blog/training-and-education/tavr-certification-program-to-increase-proficiency-of-medical-professionals-in-the-latest-technology-to-treat-coronary-artery-diseases

What is a stent? Heart stent?

A stent is a tiny tube like structure that is used in treating heart diseases due to blocked blood vessels. It helps in keeping your blood vessels open, which supply blood from the heart to the entire body including the muscles of the heart. Majority of the stents are composed out of wire mesh and are permanent in nature. Some stents used for bigger blood vessels are also composed from fabric and are termed as stent grafts. A different class of stents are manufactured from materials that get dissolved or absorbed over time in the body. They are coated with medicines that gradually get released into your blood and prevent your arteries to get clogged.

Why a stent is required? In case fats present in the body get collected inside an artery, it can decrease flow of blood to your heart itself and can lead to chest pain and eventually cause a heart disease. Also, the accumulated fat or plaque can form a blood clot disturbing the blood flow to your heart and may even lead to a heart attack due to tissue death in the affected area (Myocardial Infarction). Stents decrease your subsequent risk of heart disease and can even treat a myocardial infarction (heart attack) which is in progress. Process of stent implantation: Your doctor will first make a small incision in a blood vessel located in your abdomen, arm or neck to insert a stent in your body. He then inserts a small tube known as a catheter through the vessel to the artery which is clogged.

The tube contains a tiny balloon at its end, that your doctor will inflate in your clogged artery. This process will widen your artery and restore the blood flow through the deprived portion. The stent will then be placed inside the artery and rest of the contents (balloon and catheter) will be taken out. The placed stent will keep the artery open to keep the usual blood flow. The entire process is estimated to last only an hour but mostly, you will be required to stay in the hospital for a night for observation of any adverse events.

Risks may include:

Hemorrhage at the spot of tube insertion.
Blood vessel damage at the time of insertion.
Infection.
Arrhythmia.
In rare cases (1-2%), people implanted with a stent, may develop a clot at the site of stent placement, increasing the risk of a heart attack or stroke. This risk is maximum during the first couple of months post procedure. Hence, your doctor will recommend you to take aspirin or any other blood thinners to prevent clot formation.

For more detail visit our website- https://www.merillife.com

Our Blog – https://www.merillife.com/blog/medtech/what-is-a-stent-heart-stent/

What is a hip replacement?

You first of all need to understand, what your hip joint actually is. The hip is amongst the body’s largest joints. It is a ball-and-socket kind of joint where the socket is formed by the acetabulum, part of the large pelvis bone. On the other hand, the upper end of the thighbone (femur) forms the ball or the femoral head. The bony surfaces of the ball and the socket are covered by a smooth tissue that acts as a cushion at the bone ends to make their movement easy. This tissue is referred as articular cartilage. Another thin tissue referred to as synovial membrane also surrounds the joint.

In healthy conditions, the synovial membrane produces a fluid which lubricates the cartilage and diminishes any friction during movement of the hip, eliminating any kind of bone wear-and-tear. However, in conditions such as arthritis, the cartilage, acting as cushion between bones wears away. This wearing away causes friction between the bones of the joint leading to intense pain and stiffness. A hip replacement is a procedure involving the removal of the damaged portions of your hip joint due to friction and replacing them with artificial ones usually made of metal, ceramic or hard polymeric material.

This artificial joint/ implant aids in reduction of pain and also leads to improved joint mobility and function. A hip replacement could be recommended to you, if you are suffering from chronic hip pain which is hindering your daily activities and other non-invasive methods of pain reduction have proved to be ineffective or are no longer effective in improving your condition.

Why THR is required? The most frequent cause of needing a hip replacement is damage to the hip joint due to arthritis.

The different types of arthritis needing THR include

Osteoarthritis: It is generally referred as wear-and-tear type of arthritis. This disease causes damage to the slick cartilage that covers the bone ends and aids in smooth movement of the hip joint.
Rheumatoid Arthritis: This type of arthritis is caused by an overactive immune system, that produces an inflammatory reaction damaging the cartilage and even bones lying below the cartilage, resulting in joint damage and deformation. 3) Osteonecrosis: Bone collapse or deformation caused due to poor blood supply to the ball region in the hip joint. You can consider going for a hip replacement after consulting with your doctors, if you are suffering from any of the following conditions: 1) Persistent pain, even after taing pain-killers. 2) Pain that becomes worse with activity such as walking.
Pain that disturbs your sleep.
Pain that makes you incapable to navigate through stairs.
Pain that makes getting up from a seated position, difficult. Main steps involved in a THR are as follows:
1. The damaged ball of the hip joint is taken out and replaced with a metallic stem and is placed into the femur’s hollow center. The stem could either be cemented or “press fit” into the bone.
2. A metal or ceramic ball then replaces the worn out femoral head which was removed. This artificial ball is positioned on the stem’s upper part.
3. The cartilage surface of the socket which is damaged gets replaced with a metallic socket. In order to hold the new socket in place, screws or cement is used.
4. Finally, a metallic or plastic spacer is positioned between the new implants to permit a smooth gliding surface for frictionless movement of the joint.

For more detail visit our website – https://www.merillife.com

What is a better option for angioplasty? A bare metal stent or a drug eluded stent?

By the early nineties, Bare Metal Stents (BMS) came into the arena of angioplasty which were metallic tube-like devices that could be compressed over a balloon and later expanded in the narrowed portion of the artery. These stents were initially composed of stainless steel and later improvements led to the introduction of alloys such as cobalt-chromium for their composition. Though, these stents proved to be a defining moment in treating CAD, as they brought down the restenosis rate from 40% to 25%, a 25% rate still remained a problem. This led to further development of newer generation of stents with better designs and thinner struts. The thinner struts gave the stents enhanced flexibility and deliverability at the desired regions. Still, the percentage of restenosis remained at 25%.

Robust research and advancements led to the evolution of drug eluting stents (DES) in stent technology. The first-generation DES were composed of the same primary materials as BMS with a drug coated on to the stents. These drugs had anti-proliferative activity which selectively stopped the scar tissue proliferation at the intended area of treatment. This innovation substantially reduced the restenosis rate to a mere 3-5%. Also, the novel 3rd generation DES stents are excellent devices lending enhanced flexibility with decreased restenosis. With a 3-5% rate of restenosis with DES, majority of patients with even multiple blocks can be treated with angioplasty and can provide a 95-97% probability of disease-free survival.

The most recently developed stents (called the 4th generation) or the biodegradable stents, are composed of substances such as heavy polymers that get dissolved within the body tissues over 3-4 years after the interventional procedure. Their advantage is that they get disappeared, after performing their job. Though this is a new strategy and has yielded positive results, their long term results are still pending. Overall, though there is so far no evidence to doubt this technology and its benefits, the only cause of concern is the absence of long term data.

For more detail visit our website – https://www.merillife.com/

Our Blog – https://www.merillife.com/blog/medtech/what-is-a-better-option-for-angioplasty-a-bare-metal-stent-or-a-drug-eluded-stent/

What is knee replacement

The knee is human body’s largest joint and their healthy maintenance is required to perform most of everyday activities, easily. The knee is made up of the lower end of the thighbone (femur), the upper end of the shinbone (tibia), and the kneecap (patella). The ends of these three bones where they meet are covered with articular cartilage, a smooth substance that protects the bones and enables them to move easily. The menisci are C-shaped wedges located between the femur and tibia. These act as “shock absorbers” that cushion the joint.

Large ligaments hold the femur and tibia together and provide stability whereas, the long thigh muscles provide strength to the knee. All remaining surfaces of the knee are covered by a thin lining called the synovial membrane. This membrane releases a fluid that lubricates the cartilage, reducing friction to nearly zero in a healthy knee.

Normally, all of these components work in harmony. But disease or injury can disrupt this harmony, resulting in pain, muscle weakness, and reduced function. The most common disease responsible for disrupting the harmony and causing chronic knee pain and disability is arthritis. Although there are many types of arthritis, mostly knee pain is caused by just three types: osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis. Osteoarthritis is an age-related “wear and tear” type of arthritis. It usually occurs in people 50 years of age and older, but may occur in younger people, too. In this type of arthritis, the cartilage that cushions the bones of the knee softens and wears away.

The bones then rub against one another, causing knee pain and stiffness. Rheumatoid arthritis is a disease in which the synovial membrane that surrounds the joint becomes inflamed and thickened. This chronic inflammation can damage the cartilage and eventually cause cartilage loss, pain, and stiffness. Rheumatoid arthritis is the most common form of a group of disorders termed “inflammatory arthritis.”

Post-traumatic arthritis is a type of arthritis that can follow a serious knee injury. Fractures of the bones surrounding the knee or tears of the knee ligaments may damage the articular cartilage over time, leading to knee pain and limiting knee function. Knee replacement involves the removal of your damaged knee joint (due to arthritis or injury) and replacing it with an artificial joint. This is a major surgical procedure requiring hospital admission for 2 to 3 days. A knee replacement might be more accurately termed as knee “resurfacing” because only the surface of the bones are actually replaced.

There are four basic steps to a knee replacement procedure.

Preparation of bones: First of all, the damaged surfaces of the cartilage at the ends of the thighbone and the shinbone are removed along with a small portion of bone lying beneath the surface.
Positioning of the artificial implant: The cartilage and the bone which have been taken out are now replaced with artificial metallic components reforming. These artificial components can either be glued to the joint’s surface using a cement or simply “press-fit” into the bone.
Resurfacing the kneecap: This step involves the cutting of the inner surface of the kneecap and resurfacing it by using a plastic button. Not all surgeons will resurface the kneecap as per the patient’s condition.
Inserting the spacer: A spacer composed from medical grade plastic is then placed in the middle of the metallic parts for facilitating a friction-free movement.

For more detail visit our website – https://www.merillife.com/

Our Blog – https://www.merillife.com/blog/medtech/what-is-knee-replacement/

The Freedom Total Knee System Is The Most Innovative for Knee Replacement Surgeries In Asians

As a medical device manufacturer, we at Meril Life believe in delivering world-class health solutions with the latest and most effective medical equipment, created in our ultra-modern manufacturing facilities. We strive as global innovators and trendsetters to identify unmet clinical needs and produce relevant devices in quick turnaround cycles. Our dedicated research and development team composed of doctors, engineers, IT experts and even sales and marketing experts create an eclectic and heterogeneous team that covers every field. This empowers us to create products and therapy methods that truly focus on alleviating human suffering and improving the quality of life.

Keeping in mind this fundamental aim, we created the FREEDOM Total Knee® System. Knee replacement surgery is a common operation that involves replacing a damaged or diseased knee with an artificial joint. Most patients who undergo knee replacement surgery range from the age of 50 to 80. A closer look at the FREEDOM Total Knee® System will show you why it is one of the most effective knee replacement devices currently available.

What sets us apart

The FREEDOM Total Knee® System is the first US FDA approved knee system, with 7 tangential radii, resulting in excellent implant to bone fit. It was developed using advanced design engineering technologies to address the anatomical, physiological and lifestyle needs of today’s patients. The system’s unique and novel design allows patients to achieve optimal high flexion motion and ensures patient satisfaction. When compared to general bone replacement procedures, the FREEDOM Total Knee® System requires minimal bone cutting and enables a more conservative bone resection. Its intuitive design offers surgeons the freedom to customize their size options to better fit the implants to the patient’s knee. This makes complicated procedures and therapy methods such as an arthritis treatment, more efficient and raises success rates for both doctors and patients.

Benefits

The FREEDOM Total Knee® System streamlines the knee joint replacement process by reducing the number of trays and instruments required for the surgery. The instruments that are part of the FREEDOM Total Knee® System surgery kit are designed to be intuitive and easy to implement. The use of this system gives reproducible results while accommodating intraoperative ability. This system maximizes component interchangeability to enable simpler implantation, reduced procedure time, facilitates minimally invasive surgical approaches and decreases the time required to manipulate the system components. This gives better performance and improved patient outcomes.

Founded in 2006, Meril is an India-based, global medical device company, dedicated to innovation, design and development of novel, clinically relevant and state-of-the-art devices. Eliminating knee pain, focusing on long-term knee replacement, innovating and researching new technologies all bring us closer to our core commitment of delivering advanced healthcare solutions.

Visit our website- https://www.merillife.com/

Our Blog- https://www.merillife.com/blog/innovations/the-freedom-total-knee-system-is-the-most-innovative-for-knee-replacement-surgeries-in-asians/

Meril Life – The First Company In The World To Launch A Drug Eluting Stent With The World’s Thinnest Struts

As a medical device manufacturer, we at Meril Life believe in delivering world-class health solutions with the latest and most effective medical equipment, created in our ultra-modern manufacturing facilities. As global innovators and trendsetters, we strive to identify unmet clinical needs and produce relevant devices with quick turnaround cycles. Our dedicated research and development team empowers us to create products and therapy methods that truly focus on alleviating human suffering and improving quality of life.

Coronary artery diseases, caused by a buildup of plaque in our arteries are the world’s leading cause of death. Plaque buildup, if left unchecked can cause heart arrhythmia, cardiac arrest, heart failure and even death. The new Evermine50™, a drug-eluting coronary stent system by Meril Life, gives patients a non-surgical procedure that results in improvement in heart functions without the need for pacemakers.

What is the Evermine50™?

The Biodegradable polymer, Evermine50™ is an everolimus-eluting coronary stent system made with an ultrathin (50 μm) strut stent design. The use of catheters to deal with heart issues has been around for a while. Surgeons would implant bare-metal stents inside arteries to hold the artery open and improve blood flow to the heart. This proved to be an ineffective solution as these stents would require re-narrowing or restenosis every 6-12 months in 1 out of 3 patients. To combat this, Meril Life Sciences came up with a biocompatible and biodegradable polymer, which is a drug-eluting stent with the thinnest struts in the world. This stent does not cause restenosis and releases a drug to prevent blockage and keeps your arteries clear for a longer period of time.

What sets us apart

The Evermine50™ has a unique hybrid honey-comb cell design made from the Co-Cr L605 alloy. Its unique design gives it outstanding radial strength and visibility, while still focusing on flexibility and deliverability. The ultra-low strut thickness of just 50 µm minimises chances of vascular injury without compromising radial strength. The catheter has been designed specially with short balloon shoulders and a low balloon overhang to minimise balloon related edge injury. The stent uses a low tip entry profile and is delivered through a highly flexible system making it a healthcare solution that deals with coronary complications with minimal risk.

Benefits

We at Meril Life have our patients’ long-term safety and health as our highest priority. Compared to stents with thicker struts in the market, the Evermine50™ leads to lesser vessel injury, lowered risk of inflammation and reduced chances of thrombus formation. Clinical studies show that the Evermine50™ helps patients to avoid pacemaker implantation for up to 12 months post-procedure. With a minimally invasive procedure that leads to a shorter hospital stay and quicker recovery rates, this is a stent that puts the patient first in every manner.

Meril Life Sciences is committed to alleviate human suffering and improve the quality of life by manufacturing and delivering path-breaking medical devices and healthcare products. Our innovation, design and development all prioritise, minimising risks for patients. The Evermine50™ is just one of the many ways in which we as a medical device manufacturer hope to improve the inventiveness in healthcare and enrich people’s lives.

Visit our website- https://www.merillife.com/

Our Blog- https://www.merillife.com/blog/innovations/meril-life-the-first-company-in-the-world-to-launch-a-drug-eluting-stent-with-the-worlds-thinnest-struts/

Improving the Quality Of Human Life Through Innovative And Advanced Healthcare Solutions

Meril was born with the aim of improving the quality of human life through innovative and advanced healthcare solutions. As a medical device manufacturer, we exist to improve the inventiveness in healthcare so that people’s lives are enriched. We continually seek excellence in providing answers to some of surgical’s toughest questions.

Founded in 2006, Meril is an India-based, global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices. Our fundamental aim is to champion the alleviation of human suffering and improve quality of life.
To enable this, we are committed to R&D and innovation in manufacturing medical technology.

Our inclination towards research and development is reflected in our diverse offerings. We collaborate with physicians and global innovators to identify unmet clinical needs and develop revolutionary therapies. We encourage research and academic collaborations and remain available to interact on exciting opportunities.

Headquartered in India with a manpower of more than 4000, Meril currently conducts business in more than 100 countries. We have 100% subsidiaries in India, USA, Germany, Brazil, Russia, South Africa, Bangladesh and Turkey. We have set up operations in China and Japan too.

Meril demonstrated excellent business performance due its presence in over 100 countries globally, and a number of new, unique product launches. In FY 2018, Meril launched its Structural heart portfolio with Myval Transcatheter heart valve. Recently, Myval also received the CE mark certification approval. The company has made this technology available in European and other countries, which is a milestone achievement in Meril’s history.

Meril has its own in-house Innovation lab and training facility equipped to address customer needs and also support skill/education training. Meril’s training academy is one of the largest dedicated med-tech setups in Asia Pacific; it offers customized training programs for doctors. The company has provided training to more than 10,000 Healthcare professionals in the last few years academy in Vapi, Gujarat. Meril designed Myval and MeRes100, two such innovative technologies for treatment of vascular and valvular disease therapy areas to serve critical patients’ needs. Meril Academy organizes various training programs for the latest TAVR therapy and has trained over 400 Interventional cardiologists in a shot span of 6 months with both in-house and in-lab modules

For more detail visit our website- https://www.merillife.com

Our Blog – https://www.merillife.com/blog/about-us/improving-the-quality-of-human-life-through-innovative-and-advanced-healthcare-solutions/

Latitud Acetabular Cup System for Hip Joint Replacement | Meril Orthopedics

Latitud Acetabular Cup System

acetabular-cup-system

Modular Shell has following basic design features:

1. Modular Shell is manufactured from Ti-6Al-4V-ELI conforming to ASTM F136-13- “Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI for Surgical Implant Applications” and ISO 5832-3:1996: ” Implant for surgery-Metallic material – Part-3, Wrought Titanium 6-Aluminium 4-Vanadium alloy” and is intended to be used with mating liner.

2. Modular Shell is designed as a hemispherical geometry, press-fit shell with a porous coating on outer surface and is intended to be implanted in prepared acetabulum without bone cement (Press fit cementless fixation).

Titanium powder being used for coating conforms to ASTM F1580-12: Standard Specification for Titanium and Titanium-6Aluminum-4 Vanadium Alloy Powders for Coatings of Surgical Implants and ISO 5832-2:1999 “Implants for surgery – metallic materials – Part 2: Unalloyed titanium”
Modular Shell has internal taper and circumferential locking undercut feature to facilitate taper locking and rim locking of modular HXLPE liner with modular shell.

3. Modular Shell is provided with a threaded apical hole at dome to attach instruments for surgical insertion in prepared acetabulum.

4. Two/Three screw holes are provided in modular shell for optional additional immediate fixation through bone screws. Smaller modular shell sizes (i.e. outer diameter 40, 42, 44 mm) contain 2 holes while rest of shell sizes contains 3 holes.

5. Eight/Twelve circumferential equidistant castellation (groves or tab cut outs) are provided to fit with anti-rotational lugs (tabs) of the modular HXLPE liner component. The smaller modular shell sizes (i.e. outer diameter 40, 42, 44 mm) have eight tab cutouts at every 45º and rest of the sizes have twelve tab cut outs at every 30º. Unused tab cut outs of shell are used for modular liner extraction, if required.
6. Modular Shell is available in different sizes based on outer diameter ranging from 40 to 70 mm in 2 mm increments.

Modular liner has following basic design features:

1. Modular Liner is manufactured from HXLPE (Grade: GUR 1020) conforming to ASTM F648-14: “Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMWPE) powder and fabricated form for surgical implants.”

2. Modular Liner is available in different variants having different inner diameter (22 mm to 40 mm) and outer diameter (35 mm to 52 mm) to accept various sizes of modular femoral heads and modular shells respectively. Spherical outer geometry of modular liner fits closely with dedicated modular shell. Spherical inner geometry of modular liner is designed to suit dedicated modular femoral heads with diameters (Ø) ranging from 22 to 40 mm.

3. Modular Liner has external taper and external circumferential locking rim (protrusion) to achieve required press fit with modular shell for insertion and resistance to extraction.

4. Four/Six circumferential equidistant de-rotational lugs (tabs) are provided at the periphery of the external surface of the modular liner to fit in the castellations (grooves or tab cut outs) of modular shell. This anti-rotational tab locking feature provides anti-rotation stability to liner and also helps in visual check for full liner seating. Smaller modular liner sizes (i.e. outer diameter 35 & 37 mm) contain four de-rotation tabs located at every 90° while rest of the modular liner sizes contain six de-rotation tabs located at every 60°.

5. Modular Liner contains three circumferential equidistant (at every 120°) holes on top surface for surgical instrumentation used to insert the liner into modular shell.